{"id":"NCT00440193","sponsor":"Bayer","briefTitle":"Oral Direct Factor Xa Inhibitor Rivaroxaban in Patients With Acute Symptomatic Deep Vein Thrombosis - The EINSTEIN DVT Study","officialTitle":"Oral Direct Factor Xa Inhibitor Rivaroxaban in Patients With Acute Symptomatic Deep-Vein Thrombosis or Pulmonary Embolism","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2007-03","primaryCompletion":"2010-04","completion":"2010-04","firstPosted":"2007-02-26","resultsPosted":"2013-01-24","lastUpdate":"2014-02-27"},"enrollment":3449,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Venous Thrombosis"],"interventions":[{"type":"DRUG","name":"Rivaroxaban (Xarelto, BAY59-7939)","otherNames":[]},{"type":"DRUG","name":"Enoxaparin followed by VKA","otherNames":[]}],"arms":[{"label":"Rivaroxaban (Xarelto, BAY59-7939)","type":"EXPERIMENTAL"},{"label":"Enoxaparin/VKA","type":"ACTIVE_COMPARATOR"}],"summary":"This is a multicenter, randomized, open-label, assessor-blind, event-driven, non-inferiority program for efficacy with a study treatment duration of 3, 6 or 12 months in patients with confirmed acute symptomatic DVT without symptomatic PE (Einstein-DVT).","primaryOutcome":{"measure":"Percentage of Participants With Symptomatic Recurrent Venous Thromboembolism [VTE] (i.e. the Composite of Recurrent Deep Vein Thrombosis [DVT] or Fatal or Non-fatal Pulmonary Embolism [PE]) Until the Intended End of Study Treatment","timeFrame":"3-, 6- or 12-month study treatment period","effectByArm":[{"arm":"Rivaroxaban (Xarelto, BAY59-7939)","deltaMin":2.1,"sd":null},{"arm":"Enoxaparin/VKA","deltaMin":3,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":"< 0.0001"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":1,"exclusionCount":4},"locations":{"siteCount":324,"countries":["United States","Australia","Austria","Belgium","Brazil","Canada","China","Czechia","Denmark","Finland","France","Germany","Hong Kong","Hungary","India","Indonesia","Israel","Italy","Malaysia","Netherlands","New Zealand","Norway","Philippines","Poland","Puerto Rico","Singapore","South Africa","South Korea","Spain","Sweden","Switzerland","Taiwan","Thailand","United Kingdom"]},"refs":{"pmids":["21128814","22371186","23829521","24053656","24341332","23846019","24432872","23013426","40163217","32737096","30121419","27535349","27030066","25750589","25698905"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":222,"n":1718},"commonTop":["Nasopharyngitis","Epistaxis","Headache"]}}